Actemra 160mg, a treatment known scientifically as tocilizumab, functions as a potent therapeutical agent primarily used for the control of rheumatoid arthritis. This powerful agent acts by inhibiting the activity of interleukin-6 (IL-6), a communication protein essential in the inflammatory process. Moreover, Actemra exhibits promise in the manag